AAA
TYRA icon

Affinity Asset Advisors’s Tyra Biosciences TYRA Stock Holding History

Affinity Asset Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.86M Buy
+257,512
New +$8.34M 0.51% 50

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Affinity Asset Advisors's TYRA Position: Q1 2026 in Review

Affinity Asset Advisors opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 257,512 shares worth $9.86M. The stake represents 0.51% of the portfolio and ranks #50 among its holdings.

164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Affinity Asset Advisors held 257,512 shares of Tyra Biosciences worth $9.86M as of Q1 2026.
  • Tyra Biosciences was a new Affinity Asset Advisors position in Q1 2026.
  • Tyra Biosciences made up 0.51% of Affinity Asset Advisors's portfolio in Q1 2026, its #50 holding.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.